HomeNewsIndiaExporters need to identify niche markets, key products to boost shipments: Suresh Prabhu

Exporters need to identify niche markets, key products to boost shipments: Suresh Prabhu

In view of the present pandemic crisis, he said, the first and foremost work for exporters is to find the markets where demand support is given by their respective governments through a package, citing examples of the US and Europe.

May 23, 2020 / 18:00 IST
Story continues below Advertisement

Former union minister Suresh Prabhu has exhorted domestic exporters to identify niche markets and key products for shipments at a time when the the global market is going through a severe crisis due to COVID-19.

In view of the present pandemic crisis, he said, the first and foremost work for exporters is to find the markets where demand support is given by their respective governments through a package, citing examples of the US and Europe.

Story continues below Advertisement

Coronavirus India News LIVE Updates

"Both domestic and international markets are going through its worst-ever crisis, therefore the role of the exports sector becomes critical at this juncture. There is a need to identify niche markets and key products for exports which is the need of the hour," he said in a virtual interaction with the Federation of Indian Export Organisations (FIEO) members yesterday.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show